In the examine in breast cancer cells, The mixture of lapatinib, a dual HER2/neu and EGFR tyrosine kinase inhibitor, with INK128 prevented equally HER2 and HER3 phosphorylation induced by INK128 and created synergistic induction of cell Dying in different HER2-good cell strains immune to trastuzumab and lapatinib. In vivo (2021) https://motheru909rja0.wikibyby.com/user